SCOPUS 정보 검색 플랫폼

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 4, 2000, Pages 337-343

Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS clinical trials group 268

(6) Para, Michael F a Finkelstein, Dianne b Becker, Simone b Dohn, Michael c Walawander, Ann d Black, John R e

a OHIO STATE UNIVERSITY (United States)

b HARVARD SCHOOL OF PUBLIC HEALTH (United States)

c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE (United States)

d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION (United States)

e INDIANA UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Drug reaction; PCP prophylaxis; Pneumocystis carinii pneumonia (PCP); Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; NAUSEA; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SUSPENSION; TABLET FORMULATION;

EID: 0034253041 PISSN: 15254135 EISSN: None Source Type: Journal
DOI: 10.1097/00126334-200008010-00007 Document Type: Article

Times cited : (47)

References (26)

1
- 85030740854
- 1999 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons with human immunodeficiency vires
- No. RR-10
- (1999) MMWR Morb Mortal Wkly Rep , pp. 48

2
- 0027077785
- A controlled trial of aerosolized pentamidine or TMP/SMX as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunode-ficiency virus infection
- (1992) New Engl J Med , vol.327 , pp. 1836-1841
- Schneider, M.M.¹ Hoepelman, A.I.² Eeftinck Schattenkerk, J.K.M.³

3
- 0027478163
- Primary prophylaxis for Pneumocystis carinii pneumonia: A randomized trial comparing cotrimoxazole, aerosolized pentamidine, and dapsone plus pyrimethamine
- (1993) AIDS , vol.7 , pp. 59-64
- Mallolas, J.¹ Zamora, L.² Gatell, J.M.³

4
- 0028345232
- TMP/SMX versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: A prospective, randomized controlled clinical trial
- (1994) J Acquir Immune Defic Syndr , vol.7 , pp. 457-462
- May, Th.¹ Beuscart, C.² Reynes, J.³

5
- 85047694245
- Safety and efficacy of sul-famethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
- (1988) JAMA , vol.259 , pp. 1185-1189
- Fischl, M.A.¹ Dickinson, G.M.² LaVoie, L.³

6
- 0026034621
- Low dose co-trimoxazole for the preven-tion of Pneumocystis carinii pneumonia in human immunodeficiency virus disease
- (1991) Lancet , vol.337 , pp. 468-471
- Ruskin, J.¹ LaRiviere, M.²

7
- 0026582428
- Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia
- (1992) J Acquir Immune Defic Syndr , vol.5 , pp. 341-347
- Blum, R.N.¹ Miller, L.A.² Gaggini, L.C.³ Cohn, D.L.⁴

8
- 0033503231
- A randomized trial of daily and thrice-weekly trimethoprim/sulfamethoxazole for the prevention of Pneumocystis carinii pneu-monia in human immunodeficiency-infected person
- (1999) Clin Infect Dis , vol.29 , pp. 775-783
- El-Sadr, W.¹ Luskin-Hawk, R.² McCabe Yurik, T.³

9
- 0031002836
- Efficacy and safety of desensitization with sulfamethoxazole' and trimethoprim in 48 previously hypersensitive patients with human immunodeficiency virus
- (1997) Arch Dermatol , vol.133 , pp. 465-469
- Caumes, E.¹ Guermonprez, G.² Lecomte, C.³ Katlama, C.⁴ Bricaire, F.⁵

10
- 0027399479
- Efficacy and safety of re-challenge with low-dose trimethoprim/sulfamethoxazole in previously hypersensitive HIV-infected patients
- (1993) AIDS , vol.7 , pp. 65-71
- Carr, A.¹ Penny, R.² Cooper, D.A.³

11
- 0028918268
- Rapid desensitization to trimethoprim/sulfamethoxazole (TMP-SMX): Use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant of TMP-SMX
- (1995) Clin Infect Dis , vol.20 , pp. 849-853
- Gluckstein, D.¹ Ruskin, J.²

12
- 0028895556
- Rapid oral desensitization to sulfonamides in patients with acquired im-munodeficiency syndrome
- (1995) Ann Allergy Asthma Immunol , vol.74 , pp. 140-146
- Moreno, J.N.¹ Poblete, R.B.² Maggio, C.³ Gagnon, S.⁴ Fischl, M.A.⁵

13
- 0025365073
- Desensitization to sulfonamides in pa-tients with HIV infection
- (1990) Am J Med , vol.88 , pp. 548-549
- Torgovnick, J.¹ Arsura, E.²

14
- 0007526505
- Trimethoprim/sulfamethoxazole hypersensitivity and desensitization in HIV disease [abstract no. PoB 3291]. Presented at the VIII International Conference on AIDS, Amsterdam
- (1992)
- Conant, M.¹ Dybul, M.²

15
- 0028920743
- A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection
- (1995) N Engl J Med , vol.332 , pp. 693-699
- Bozzette, S.A.¹ Finkelstein, D.M.² Spector, S.A.³

16
- 0007568074
- Categorical data analysis. New York: John Wiley and Son
- (1990) , pp. 572
- Agresti, A.¹

17
- 0030000040
- Tests for treatment comparisons base on recurrent event responses
- (1996) Biometrics , vol.52 , pp. 557-571
- Cook, R.J.¹ Lawless, J.F.² Nadeau, C.R.³

18
- 0027082592
- Drug hypersensitivity re-actions and Human Immunodeficiency Virus disease
- (1992) J Acquir Immune Defic Syndr , vol.5 , pp. 1237-1257
- Bayard, P.J.¹ Berger, T.G.² Jacobson, M.A.³

19
- 84933688596
- The sulfonamides
- Goodman LS, Gilman AG, eds. The pharmacological basis of therapeutics, 4th ed. New York: Macmillan
- (1970) , pp. 1177-1203
- Weinstein, L.¹

20
- 0021813284
- N-acetylation pharmacogenetics
- (1985) Pharmacol Rev , vol.37 , pp. 25-79
- Weber, W.W.¹ Hein, D.W.²

21
- 0031467258
- Acetylator status and tolerance of high-dose trimethoprim/sulfamethoxazole therapy among patients infected with human immunodeficiency virus
- (1997) Clin Infect Dis , vol.25 , pp. 1477-1478
- Smith, C.L.¹ Brown, I.² Torraca, B.M.³

22
- 0024584277
- Diagnosis of sulfonamide hypersensitivity reactions by in-vitro 'rechallenge' with hydroylamine metabolites
- (1989) Ann Intern Med , vol.110 , pp. 286-289
- Rieder, M.J.¹ Uetrecht, J.² Shear, N.H.³ Cannon, M.⁴ Miller, M.⁵ Spielberg, S.P.⁶

23
- 0007526056
- Recurrence of trimethoprim/sulfamethoxazole hypersensitivity following initiation of protease inhibitors in patients with advanced HIV-1 [abstract 535]. Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC
- (1997)
- Race, E.¹ Reimann, K.² Letvin, N.³ Japour, A.⁴

24
- 0007483799
- Treatment with protease inhibitors in HIV-infected patients: are hypersensitivity reactions more common [abstract no. I-186]. Pro-gram and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto
- (1997)
- Quirino, T.¹ Bonfanti, P.² Capetti, A.³ Testa, L.⁴ Riva, P.⁵ Rizzardini, G.⁶

25
- 0030767715
- Management of drug interactions in patients with HIV
- (1997) Ann Pharmacother , vol.31 , pp. 1040-1058
- Lin-In Tseng, A.¹ Foisy, M.M.²

26
- 0028930117
- High-dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
- (1995) J Infect Dis , vol.171 , pp. 537-545
- Havlir, D.¹ Cheeseman, S.H.² McLaughlin, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.